← FDA Drug Approvals (Drugs@FDA)

MESALAMINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: QUAGEN · Approved 2015-11-24

Drug application

FDA Application #

ANDA204354

Application type

Abbreviated New Drug Application (Generic)

Brand name

MESALAMINE

Generic name

Mesalamine

Active ingredients

MESALAMINE

Dosage form

SUPPOSITORY

Route

RECTAL

Marketing status

Prescription

Sponsor

QUAGEN

First approval

2015-11-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown